RXL-141 10mg Research Compound | Third-Party Tested | RemedyX

RXL-141 10mg synthetic peptide for laboratory and analytical research. Lot-specific COA available. Research use only; not for human or veterinary use.

Research Overview

RXL-141 is a synthetic melanocortin receptor agonist, active at MC3R and MC4R, studied in controlled laboratory models of melanocortin receptor signaling and central nervous system research.

Each lot undergoes independent third-party analytical testing, with the lot-specific Certificate of Analysis published on this page.

This product is intended exclusively for lawful in-vitro laboratory research and analytical reference use by qualified professionals. It is not approved for, and must not be used for, human or veterinary consumption, medical or therapeutic purposes, diagnostic applications, or any form of in-vivo administration. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

Batch documentation

Review the public batch records and Certificates of Analysis associated with this product.

Related research products

Public research products currently presented in the related-products section.

RXL-141 10mg synthetic peptide for laboratory and analytical research. Lot-specific COA available. Research use only; not for human or veterinary use.